Long-term Follow-up of Anxiety and Depression in Patients With Malignant Tumors

Depression Clinical Trial

Official title:

A Single-center, Real-world Prospective Observational Study of the Incidence and Development of Anxiety and Depression in Patients With Malignant Tumors

Clinical Trial Details — Status: Recruiting

Administrative data

• NCT number: NCT05596344
• Other study ID #: ZZUSC-16
• Status: Recruiting
• Start date: May 20, 2023
• Est. completion date: November 30, 2032

Study information

• Verified date: October 2023
• Source: Henan Cancer Hospital
• Contact: Wang Jiaqiang, Dr
• Phone: 13592413731
• Email: wjqwtj[@]126.com
• Is FDA regulated: No
• Study type: Observational

Clinical Trial Summary

This study was a single-center prospective, real-world observational study with plans to enroll all eligible patients. The basic information, anxiety and depression, treatment and prognosis of these patients were collected.

Description:

A total of 200 patients with malignant tumors will be enrolled in Henan Cancer Hospital. This study is a single-center prospective real-world observational study, and all eligible patients are planned to be enrolled. The basic information, anxiety and depression, treatment and prognosis of these patients were collected.

Recruitment information / eligibility

• Status: Recruiting
• Enrollment: 200
• Est. completion date: November 30, 2032
• Est. primary completion date: November 30, 2032
• Accepts healthy volunteers: No
• Gender: All
• Age group: N/A and older

Eligibility

Inclusion Criteria:

1. Men and women of all ages are welcome.

2. Pathological diagnosis of malignant tumor in our hospital.

3. Received at least one hospitalization at this hospital.

4. The expected survival time is greater than 1 year. Exclusion Criteria: 1.There was no pathological report of malignancy.

Related Conditions & MeSH terms

• Anxiety
• Anxiety Disorders
• Depression
• Depressive Disorder
• Malignant Tumor
• Neoplasms

Intervention

Other:
• Hospital Anxiety and Depression Scale
The basic information, anxiety and depression, treatment and prognosis of these patients were collected.

Locations

Country	Name	City	State
China	Department of Bone and Soft Tissue ,Henan Cancer Hospital	Zhengzhou	Henan

Sponsors (1)

Lead Sponsor	Collaborator
Henan Cancer Hospital

Country where clinical trial is conducted

China, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Hospital Anxiety Depression Scale	Confirmed in 1 day	Confirmed in 1 day
Primary	Hospital Anxiety Depression Scale	End of the treatment	End of the treatment
Primary	Hospital Anxiety Depression Scale	The treatment ended 3 months later	The treatment ended 3 months later
Primary	Hospital Anxiety Depression Scale	The treatment ended 6 months later	The treatment ended 6 months later
Primary	Hospital Anxiety Depression Scale	The treatment ended one year later	The treatment ended one year later
Primary	Hospital Anxiety Depression Scale	The treatment ended 2 years ago	The treatment ended 2 years ago